COVID-19/ INDICAID (5 Tests)

Product Description

(Box with 5 Tests) The INDICAID Rapid Antigen Test is a FDA Authorized and CE-marked lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.

Clinically validated with overall sensitivity and specificity at 96% and 99% respectively, INDICAID provides intuitive visual results in 20 minutes. No special equipment or facilities needed.

INDICAID is designed for primary screening only. If you have any doubts about the test results, seek medical advise immediately. The Test result should be used in conjunction with other clinical information to diagnose COVID-19 infection. If you are suspecting an infection, feeling unwell or have any symptoms such as fever, cough, runny nose, sore throat, you should consult medical professionals immediately for the confirmation of diagnosis.

Important:

• The test must be performed between 18-25°C
• Store at 2-30°C. Do not freeze
• Avoid direct sunlight
• Do not swallow or inhale
Read More

Product Highlights

Up to 96% Sensitivity
Early Detection
Results in 20 min

FDA Authorized
5 Tests
Nasal Swab

Technical Information

Type	Lateral Flow Detection (LFD) In-vitro Qualitative Detection
Specimen	Nasopharyngeal Swab
Reusable	No (Single-Time Use)
Sensitivity	Sensitivity: 96% Specificity: 99%
Result Time	20 minutes
Detection	SARS-CoV-2 Virus Antigen
Certifications	FDA Authorization (Emergency Use), CE
Manufacturer	Phase Scientific International
Origin	Hong Kong